ATA217578A - Verfahren zur herstellung des neuen kristallinen monohydrates von natrium-7-(d-2- hydroxy-2-phenylacetamido)-3-(1-methyl-1h- tetrazol-5-yl-thiomethyl)-3-cephem-4- carboxylat - Google Patents

Verfahren zur herstellung des neuen kristallinen monohydrates von natrium-7-(d-2- hydroxy-2-phenylacetamido)-3-(1-methyl-1h- tetrazol-5-yl-thiomethyl)-3-cephem-4- carboxylat

Info

Publication number
ATA217578A
ATA217578A AT782175A AT217578A ATA217578A AT A217578 A ATA217578 A AT A217578A AT 782175 A AT782175 A AT 782175A AT 217578 A AT217578 A AT 217578A AT A217578 A ATA217578 A AT A217578A
Authority
AT
Austria
Prior art keywords
phenylacetamido
cephem
thiomethyl
tetrazol
carboxylate
Prior art date
Application number
AT782175A
Other languages
English (en)
Other versions
AT349148B (de
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ATA217578A publication Critical patent/ATA217578A/de
Application granted granted Critical
Publication of AT349148B publication Critical patent/AT349148B/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT217578A 1975-12-22 1976-12-21 Verfahren zur herstellung des neuen kristallinen monohydrates von natrium-7-(d-2- hydroxy-2-phenylacetamido)-3-(1-methyl-1h- tetrazol-5-yl-thiomethyl)-3-cephem-4- carboxylat AT349148B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/642,922 US4054738A (en) 1975-12-22 1975-12-22 Sodium cefamandole crystalline forms

Publications (2)

Publication Number Publication Date
ATA217578A true ATA217578A (de) 1978-08-15
AT349148B AT349148B (de) 1979-03-26

Family

ID=24578600

Family Applications (2)

Application Number Title Priority Date Filing Date
AT948976A AT348678B (de) 1975-12-22 1976-12-21 Verfahren zur herstellung des neuen kristallinen anhydrats von natrium-7-(d-2-hydroxy-2-phenylacetamido)-3-(1- methyl-1h-tetrazol-5-yl-thiomethyl)-3-cephem-4- carboxylat
AT217578A AT349148B (de) 1975-12-22 1976-12-21 Verfahren zur herstellung des neuen kristallinen monohydrates von natrium-7-(d-2- hydroxy-2-phenylacetamido)-3-(1-methyl-1h- tetrazol-5-yl-thiomethyl)-3-cephem-4- carboxylat

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT948976A AT348678B (de) 1975-12-22 1976-12-21 Verfahren zur herstellung des neuen kristallinen anhydrats von natrium-7-(d-2-hydroxy-2-phenylacetamido)-3-(1- methyl-1h-tetrazol-5-yl-thiomethyl)-3-cephem-4- carboxylat

Country Status (31)

Country Link
US (1) US4054738A (de)
JP (2) JPS5282714A (de)
AR (1) AR213300A1 (de)
AT (2) AT348678B (de)
AU (1) AU505924B2 (de)
BE (1) BE849415A (de)
CA (1) CA1080696A (de)
CH (1) CH628348A5 (de)
CS (1) CS195746B2 (de)
DD (1) DD128727A5 (de)
DE (1) DE2654647C2 (de)
DK (1) DK153156C (de)
FI (1) FI66008C (de)
FR (3) FR2361898A1 (de)
GB (1) GB1565854A (de)
GR (1) GR65891B (de)
HU (1) HU172474B (de)
IL (3) IL50977A (de)
LU (1) LU76435A1 (de)
MX (1) MX3840E (de)
NL (1) NL187483C (de)
NO (1) NO148887C (de)
NZ (1) NZ182694A (de)
OA (1) OA05518A (de)
PH (1) PH12191A (de)
PL (1) PL102739B1 (de)
PT (1) PT65955B (de)
RO (3) RO75964A (de)
SE (3) SE424730B (de)
SU (3) SU637087A3 (de)
ZA (1) ZA766957B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4168376A (en) * 1978-06-05 1979-09-18 Eli Lilly And Company Process for crystalline sodium cefamandole
US4237279A (en) * 1979-07-27 1980-12-02 Eli Lilly And Company Crystalline 3-hydroxycephalosporin solvates
DE3313816A1 (de) * 1983-04-16 1984-10-18 Hoechst Ag, 6230 Frankfurt Neue kristallmodifikation von ceftazidim
DE3313818A1 (de) * 1983-04-16 1984-10-18 Hoechst Ag, 6230 Frankfurt Neue kristallmodifikation von ceftazidim
CA1242699A (en) * 1985-02-01 1988-10-04 Bristol-Myers Company Cefbuperazone and derivatives thereof
JPH0677412B2 (ja) * 1985-05-03 1994-09-28 株式会社フジクラ 高圧直流送電用電力ケーブル
JPS629495U (de) * 1985-07-01 1987-01-21
GB9717629D0 (en) 1997-08-21 1997-10-22 Johnson Matthey Plc Removal of residual organic solvents

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3496171A (en) * 1969-02-17 1970-02-17 Lilly Co Eli Process for improving the physical and chemical properties of cephaloglycin
US3641021A (en) * 1969-04-18 1972-02-08 Lilly Co Eli 3 7-(ring-substituted) cephalosporin compounds
US3692781A (en) * 1971-02-26 1972-09-19 Glaxo Lab Ltd Recovery of pure cephalexin from acidic reaction mixtures
US3819620A (en) * 1972-06-01 1974-06-25 Squibb & Sons Inc 7-(d-alpha-amino-1,4-cyclohexadien-1-ylacet-amido)desacetoxycephalosporanic acid dihydrate
US3862186A (en) * 1972-12-15 1975-01-21 Bristol Myers Co Process for the production of cephalexin monohydrate
US3928592A (en) * 1974-02-22 1975-12-23 Lilly Co Eli Antibiotic pharmaceutical compositions

Also Published As

Publication number Publication date
FR2351984A1 (fr) 1977-12-16
FR2361898B1 (de) 1980-03-14
HU172474B (hu) 1978-09-28
ATA948976A (de) 1978-07-15
IL50977A (en) 1980-02-29
FR2361898A1 (fr) 1978-03-17
DK153156C (da) 1989-02-20
MX3840E (es) 1981-08-11
CS195746B2 (en) 1980-02-29
AU505924B2 (en) 1979-12-06
RO69709A (ro) 1980-04-15
ZA766957B (en) 1978-06-28
SE7614401L (sv) 1977-06-23
FR2351985B1 (de) 1980-06-27
CA1080696A (en) 1980-07-01
RO75963A (ro) 1981-02-28
AT348678B (de) 1979-02-26
SU1018585A3 (ru) 1983-05-15
DE2654647A1 (de) 1977-06-30
FR2351985A1 (fr) 1977-12-16
BE849415A (fr) 1977-06-15
AT349148B (de) 1979-03-26
PL102739B1 (pl) 1979-04-30
SU671732A3 (ru) 1979-06-30
SU637087A3 (ru) 1978-12-05
IL50977A0 (en) 1977-01-31
GR65891B (de) 1980-12-01
AR213300A1 (es) 1979-01-15
FI763682A7 (de) 1977-06-23
JPS61351B2 (de) 1986-01-08
PH12191A (en) 1978-11-21
CH628348A5 (de) 1982-02-26
IL57387A0 (en) 1979-09-30
SE8201701L (sv) 1982-03-17
FI66008C (fi) 1984-08-10
JPS5282714A (en) 1977-07-11
LU76435A1 (de) 1977-06-10
NZ182694A (en) 1978-09-25
US4054738A (en) 1977-10-18
NO148887C (no) 1984-01-04
SE424730B (sv) 1982-08-09
DE2654647C2 (de) 1982-06-24
DD128727A5 (de) 1977-12-07
OA05518A (fr) 1981-04-30
AU2001376A (en) 1978-06-01
FI66008B (fi) 1984-04-30
SE443564B (sv) 1986-03-03
GB1565854A (en) 1980-04-23
NL7614233A (nl) 1977-06-24
SE441096B (sv) 1985-09-09
JPS6183189A (ja) 1986-04-26
IL57386A0 (en) 1979-09-30
NL187483B (nl) 1991-05-16
DK575576A (da) 1977-06-23
NO764222L (de) 1977-06-23
NO148887B (no) 1983-09-26
RO75964A (ro) 1981-02-28
FR2351984B1 (de) 1980-06-27
PT65955B (en) 1978-06-15
PT65955A (en) 1977-01-01
JPS624393B2 (de) 1987-01-30
NL187483C (nl) 1991-10-16
DK153156B (da) 1988-06-20
SE8201702L (sv) 1982-03-17

Similar Documents

Publication Publication Date Title
DD138423A5 (de) Verfahren zur herstellung von cephemderivaten
AT345795B (de) Verfahren zur herstellung von neuen phenylalkancarbonsaeure-derivaten
AT350722B (de) Verfahren zur herstellung von neuen kanamycin- derivaten
ATA217578A (de) Verfahren zur herstellung des neuen kristallinen monohydrates von natrium-7-(d-2- hydroxy-2-phenylacetamido)-3-(1-methyl-1h- tetrazol-5-yl-thiomethyl)-3-cephem-4- carboxylat
ATA126476A (de) Verfahren zur herstellung von neuen 3-acyloxymethyl-cephem-verbindungen
AT349143B (de) Verfahren zur herstellung von neuen derivaten der 3-carbamoyloxy-methyl-7-(amino-4- thiazolyl-acetamido)-cephalosporansaeure
AT347963B (de) Verfahren zur herstellung von neuen 4- halogenazetidinon-1-essigsaeurederivaten
ATA851176A (de) Verfahren zur herstellung des neuen trinatriumsalzes von 2-carboxymethyloxymalonsauremonohydrat
DD132344A5 (de) Verfahren zur herstellung von beta-lactam-antibiotika
AT353278B (de) Verfahren zur herstellung von neuen azetidin- derivaten
AT341674B (de) Verfahren zur herstellung von 7- (d-2-amino-3-phenylacetamido)-3-methyl-3-cephem-4-carbonsaure
ATA52878A (de) Verfahren zur herstellung des neuen lysinsalzes der alpha-methyl-(2-isopropyl-indan-5-yl)- essigsaeure
AT349149B (de) Verfahren zur herstellung des neuen kristallinen methanolats von natrium-7-(d-2- hydroxy-2-phenylacetamido)-3-(1-methyl-1h- tetrazol-5-yl-thiomethyl)-3-cephem-4- carboxylat
ATA69676A (de) Verfahren zur herstellung von neuen bis-triarylphosphoniumsalzen
AT349476B (de) Verfahren zur herstellung von neuen phenoxy- alkancarbonsaeurederivaten von 1-cinnamyl-4- diphenylmethylpiperazin
ATA716477A (de) Verfahren zur herstellung von cephalosporin- verbindungen
AT346354B (de) Verfahren zur herstellung von neuen 2- morpholinonderivaten
PT67138B (de) Verfahren zur herstellung des magnesiumsalzes der p-chlorphenoxyisobuttersaure
ATA569180A (de) Verfahren zur herstellung von cephalosporansaeure- derivaten
ATA554180A (de) Verfahren zur herstellung von cephalosporansaeure- derivaten
ATA475677A (de) Verfahren zur herstellung von neuen phenylalkancarbonsaeure-derivaten
ATA721977A (de) Verfahren zur herstellung von neuen dipeptid- -derivaten
AT347036B (de) Verfahren zur herstellung von neuen cephalosporinderivaten
AT350186B (de) Verfahren zur herstellung von neuen cephalosporinderivaten
AT340049B (de) Verfahren zur herstellung von neuen 7-(3-alkansulfonamidophenyl-d-glycinamido)-3-methyl-3-cephem-4-carbonsauren

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
UEP Publication of translation of european patent specification